Interaction Between Photodynamic Therapy and BCG Immunotherapy Responsible for the Reduced Recurrence of Treated Mouse Tumors¶
- 1 May 2007
- journal article
- Published by American Society for Photobiology in Photochemistry and Photobiology
- Vol. 73 (4) , 403-409
- https://doi.org/10.1562/0031-8655(2001)0730403ibptab2.0.co2
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG)Published by Elsevier ,2004
- Structurally well‐defined macrophage activating factor derived from vitamin D3‐binding protein has a potent adjuvant activity for immunizationImmunology & Cell Biology, 1998
- Localization and Efficacy Analysis of the Phototherapeutic Lutetium Texaphyrin (PCI‐0123) in the Murine EMT6 Sarcoma ModelPhotochemistry and Photobiology, 1997
- A Role for L‐Selectin in Monocyte Activation by Jurkat Tumour CellsScandinavian Journal of Immunology, 1996
- Lutetium Texaphyrin (PCI‐0123): A Near‐Infrared, Water‐Soluble PhotosensitizerPhotochemistry and Photobiology, 1996
- Urinary Cytokines During Intravesical Bacillus Calmetteguerin Therapy for Superficial Bladder Cancer: Processing, Stability and Prognostic ValueJournal of Urology, 1996
- T and B memory cellsCell, 1994
- HOW DOES PHOTODYNAMIC THERAPY WORK?Photochemistry and Photobiology, 1992
- Detection of urinary TNF, IL 1, and IL 2 after local BCG immunotherapy for bladder carcinomaCytokine, 1990
- BACILLUS CALMETTE‐GUÉRIN CONTACT IMMUNOTHERAPY OF LOCAL AND METASTATIC DEPOSITS OF RAT TUMORS*Annals of the New York Academy of Sciences, 1976